Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Startseite Know-how Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

The aim of this study was to compare the humoral immune response provided by four commercialised reproductive vaccines against swine erysipelas (SE) and porcine parvovirus (PPV), under field conditions in Denmark. 

Über diesen Artikel

Veröffentlicht in

European Symposium of Porcine Health Management, 2018

Datum

10.07.2018

Verfasser

Pedersen, K.S.; Camprodon, A.; Llopart, D.; Jorda, R.; Strunz, A.M.

Zusammenfassung

Gilts vaccinated with ERYSENG® PARVO exhibited the highest serological response compared with animals vaccinated with one of the other three commercialised vaccines against E. rhusiopathiae.

Ähnliche Produkte

Teilen

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}